Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ISRCTN15862521) titled 'Levosimendan in out of hospital cardiac arrest' on Oct. 22.
Study Type: Interventional
Study Design:
Phase II investigator-initiated randomized parallel-group placebo-controlled double-blinded pilot trial (Treatment)
Primary Sponsor: Karolinska University Hospital
Condition:
Out-of-hospital cardiac arrest
Circulatory System
Intervention:
The randomisation is done using an online randomisation tool.
The intervention is one intravenous bolus injection of levosimendan or placebo during ongoing prehospital CPR.
1. A prefilled, blinded, syringe with 50 ml of study drug: levosimendan 2.5 mg (2.5 mg/ml, 1 ml in ...